XML 72 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of share-based compensation expenses

Year ended December 31, 

    

2021

2022

    

2023

(in thousands)

Cost of revenues

$

682

 

481

 

157

Research and development

17,662

 

15,345

 

9,414

General and administrative

2,367

 

2,193

 

1,108

Sales and marketing

3,163

 

2,612

 

1,453

Total compensation

$

23,874

 

20,631

 

12,132

Income tax benefit

$

4,896

 

4,201

 

2,545

Schedule of RSUs activity under the long-term incentive plan

    

Number of

    

Weighted

Underlying

Average Grant

Shares for RSUs

Date Fair Value

Balance at January 1, 2021

 

22,889

$

3.88

Granted

2,604,545

10.39

Vested

(2,237,499)

10.37

Forfeited

(3,415)

4.38

Balance at December 31, 2021

 

386,520

 

10.17

Granted

 

3,987,509

 

5.09

Vested

 

(3,563,177)

 

5.25

Forfeited

 

(18,643)

 

10.15

Balance at December 31, 2022

 

792,209

 

6.71

Granted

1,710,607

5.68

Vested

(1,974,496)

5.91

Forfeited

(2,355)

9.81

Balance at December 31, 2023

525,965

6.36

Schedule of allocation of compensation expenses and related tax effects from the RSUs granted to employees under the long-term incentive plan

Year ended December 31, 

    

2021

2022

    

2023

(in thousands)

Cost of revenues

$

676

 

472

 

153

Research and development

17,592

 

15,097

 

9,353

General and administrative

2,343

 

1,934

 

1,108

Sales and marketing

3,149

 

2,497

 

1,449

Total compensation

$

23,760

 

20,000

 

12,063

Income tax benefit

$

4,896

 

4,201

 

2,545

Schedule of valuation assumptions

    

2019 plan

 

Valuation assumptions:

 

  

Expected dividend yield

 

3.5

%

Expected volatility

 

51.96%-57.79

%

Expected term (years)

 

1-1.5

Risk-free interest rate

 

1.69%-1.75

%

Schedule of stock option activity

Weighted

Weighted

average

average

remaining

Number

exercise

contractual

    

of Units

    

price

    

term

Balance at January 1, 2021

 

578,468

$

2.36

 

0.54

Exercised

(524,387)

2.37

Expired

(54,081)

2.27

Balance at December 31, 2021

Exercisable at December 31, 2021

 

CM Visual Technology Corp  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2021 plan

Granted in

Granted in

2021

2023

Valuation assumptions:

Expected dividend yield

 

0%

 

0%

Expected volatility

 

43.82%

 

44.17%

Expected term (years)

 

3.125

 

3.125

Risk-free interest rate

 

0.223%

 

1.081%

Schedule of stock option activity

    

    

    

    

    

Weighted

 

 

Weighted

 

average

 

 

average

 

remaining

Number

 

exercise

 

contractual

of shares

 

price

 

term

Balance at January 1, 2021

 

$

Granted

 

2,791,000

 

0.36

 

  

Exercised

 

 

 

  

Forfeited

 

(120,000)

 

0.36

 

  

Balance at December 31, 2021

 

2,671,000

 

0.36

 

3.5

Exercised

Forfeited

(380,000)

0.36

Balance at December 31, 2022

2,291,000

0.36

2.5

Granted

288,000

0.33

Exercised

Effect of capital reduction

(1,289,500)

0.36

Forfeited

Balance at December 31, 2023

1,289,500

0.50

1.5

Exercisable at December 31, 2023

 

572,750

 

0.50

 

1.5

Liqxtal Technology Inc  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2021 plan

Valuation assumptions:

Expected dividend yield

 

0%

Expected volatility

 

30.06%

Expected term (years)

 

1.25

Risk-free interest rate

 

0.107%

Schedule of stock option activity

    

    

    

    

    

Weighted

 

Weighted

 

average

 

average

 

remaining

 

Number

 

exercise

 

contractual

 

of shares

 

price

 

term

Balance at January 1, 2021

 

$

 

  

Granted

 

1,000,000

 

0.65

 

  

Exercised

 

 

 

  

Forfeited

 

(90,000)

 

0.65

 

  

Balance at December 31, 2021

 

910,000

 

0.65

 

1.0

Exercised

(840,000)

0.65

Forfeited

(70,000)

0.65

Balance at December 31, 2022

Exercisable at December 31, 2022

 

 

 

Emza  
Disclosure Of Share Based Payment Arrangements Explanatory [Line Items]  
Schedule of valuation assumptions

    

2022 Option Plan

 

Valuation assumptions:

 

Expected dividend yield

 

0

%

Expected volatility

 

54.05

%

Expected term (years)

 

6.11

Risk-free interest rate

 

0.65

%

Schedule of stock option activity

    

    

    

Weighted

Weighted

average

average

remaining

Number

exercise

contractual

of shares

price

term

Balance at January 1, 2022

 

$

 

Granted

 

150,940

 

20.49

 

6.11

Exercised

 

 

 

Forfeited

 

(1,797)

 

20.49

 

Cancelled

 

(149,143)

 

20.49

 

Balance at December 31, 2022

 

 

 

Exercisable at December 31, 2022